Glipizide And Metformin Hydrochloride Tablet, Film Coated
FDA Label NDC 65841-661

1 label section · Submitted to the FDA by Zydus Lifesciences Limited · Indications, Dosage, Usage, and Precautions

Structured Product Label

The following Structured Product Label (SPL) was submitted to the FDA by Zydus Lifesciences Limited for the product Glipizide And Metformin Hydrochloride (NDC 65841-661). This document serves as the official prescribing information, containing essential scientific data and clinical materials required for healthcare providers and patients.

This specific version of the label includes detailed information regarding package label.principal display panel, and other regulatory disclosures. Use the navigation below to review specific sections of the FDA submission.

Package Label.Principal Display Panel

NDC 65841-659-01 in bottle of 100 tablets

Glipizide and Metformin Hydrochloride Tablets USP, 2.5 mg/250 mg

Rx only

100 tablets

Glipizide And Metformin HCl Tablets (D182433b E6d4 4939 9905 B0960cfe0691 01)

Glipizide And Metformin HCl Tablets (D182433b E6d4 4939 9905 B0960cfe0691 01)

NDC 65841-660-01 in bottle of 100 tablets

Glipizide and Metformin Hydrochloride Tablets USP, 2.5 mg/500 mg

Rx only

100 tablets

Glipizide And Metformin HCl Tablets (D182433b E6d4 4939 9905 B0960cfe0691 02)

Glipizide And Metformin HCl Tablets (D182433b E6d4 4939 9905 B0960cfe0691 02)

NDC 65841-661-01 in bottle of 100 tablets

Glipizide and Metformin Hydrochloride Tablets USP, 5 mg/500 mg

Rx only

100 tablets

Glipizide And Metformin HCl Tablets (D182433b E6d4 4939 9905 B0960cfe0691 03)

Glipizide And Metformin HCl Tablets (D182433b E6d4 4939 9905 B0960cfe0691 03)

* Please review the disclaimer below.